- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HER2-
Total 2787 results
-
Ain Shams UniversityCompletedEndometrial ThicknessEgypt
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingEdema | Erythema | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Recurrent Inflammatory Breast Carcinoma | Stage IV Inflammatory Breast Carcinoma | Peau d'OrangeUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Hoffmann-La RocheRecruiting
-
M.D. Anderson Cancer CenterDaiichi SankyoRecruiting
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompleted
-
German Breast GroupCompleted
-
Stephen ShiaoUnited States Department of DefenseActive, not recruiting
-
Boehringer IngelheimRecruitingNeoplasm Metastasis | Non-Small Cell Lung CancerUnited States, Hong Kong, Spain, Korea, Republic of, China, Israel, Germany, Japan, Singapore, Australia, United Kingdom, Austria, Netherlands, France, Portugal, Sweden, Italy, Belgium
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.Unknown
-
Fondazione del Piemonte per l'OncologiaUnknown
-
Hoffmann-La RocheCompleted
-
PfizerRecruitingAdvanced or Metastatic Breast CancerUnited States, Taiwan, Canada, Japan, China, Korea, Republic of, Israel, Argentina, Mexico, Australia, Brazil, United Kingdom, India
-
Artios Pharma LtdActive, not recruitingBreast Cancer | Metastatic Cancer | Advanced CancerUnited States, United Kingdom
-
Emory UniversityTerminatedBreast Cancer | Breast Neoplasms | Cancer of the BreastUnited States
-
Virginia Commonwealth UniversityActive, not recruitingBreast Cancer | Invasive Breast Carcinoma | Lobular Breast Carcinoma In Situ | Breast Adenocarcinoma | Node-positive Breast CancerUnited States
-
NSABP Foundation IncPfizer; Genomic Health®, Inc.CompletedBreast CancerUnited States, Canada
-
Cedars-Sinai Medical CenterAstraZenecaWithdrawnBreast Cancer | Triple Negative Breast CancerUnited States
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Jules Bordet InstituteWithdrawn
-
Hoffmann-La RocheCompletedBreast CancerHungary, Italy, Spain, France, United Kingdom, Belgium, Germany, Portugal, Poland, Canada, Bulgaria, Mexico
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.Unknown
-
National University Hospital, SingaporeNational Cancer Centre, SingaporeUnknown
-
Ain Shams UniversityCompleted
-
PfizerActive, not recruitingSafety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)Breast Neoplasms | Colorectal Cancer | Metastatic HER2+ Advanced Breast Cancer | Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)China
-
Assiut UniversityCompleted
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Terminated
-
Huihua XiongNot yet recruiting
-
Fudan UniversityRecruitingGastric Cancer/Adenocarcinoma of Esophagogastric JunctionChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Seagen Inc.RecruitingAnatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC... and other conditionsUnited States, Canada, Puerto Rico
-
Daiichi Sankyo Co., Ltd.CompletedGastric CancerKorea, Republic of, Hong Kong, Taiwan, China
-
NSABP Foundation IncPuma Biotechnology, Inc.CompletedBreast CancerUnited States, Canada, Puerto Rico, Italy, Spain
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
Translational Research in OncologyTerminated
-
SanofiCompleted
-
Hospices Civils de LyonNot yet recruiting
-
Fudan UniversityRecruiting
-
AstraZenecaDaiichi SankyoCompletedBreast CancerDenmark, Finland, Italy, Norway, Spain, Sweden, Poland, United States, Canada, Germany, Japan, Netherlands, Portugal, Switzerland, Australia, United Kingdom, Belgium, Ireland
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast Cancer | Cardiac ToxicityUnited States
-
Boehringer IngelheimCompleted
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
National Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid... and other conditionsUnited States, Puerto Rico
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
PfizerCompletedBreast Cancer | Breast Neoplasms | Breast Tumors | Breast Carcinoma | Cancer of BreastIndia
-
National Cancer Institute (NCI)CompletedCombination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast CancerStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
BeiGeneRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive...Australia, United States
-
M.D. Anderson Cancer CenterGenentech, Inc.; Seagen Inc.RecruitingMetastatic Solid Tumor | Brain MetastasesUnited States